{"id":"https://openalex.org/W2560048845","doi":"https://doi.org/10.1093/ofid/ofw172.1833","title":"Dasatinib Use May Be a Novel Risk Factor for Cytomegalovirus (CMV) Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)","display_name":"Dasatinib Use May Be a Novel Risk Factor for Cytomegalovirus (CMV) Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)","publication_year":2016,"publication_date":"2016-01-01","ids":{"openalex":"https://openalex.org/W2560048845","doi":"https://doi.org/10.1093/ofid/ofw172.1833","mag":"2560048845"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofw172.1833","doi":"https://doi.org/10.1093/ofid/ofw172.1833","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofw172.1833","pdf_url":"https://academic.oup.com/ofid/article-pdf/3/suppl_1/2286/28689513/ofw172.1833.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/ofid/article-pdf/3/suppl_1/2286/28689513/ofw172.1833.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112615633","display_name":"Daniel Prestes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210149843","display_name":"Hospital S\u00edrio-Liban\u00eas","ror":"https://ror.org/03r5mk904","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210149843"]}],"countries":["BR","US"],"is_corresponding":false,"raw_author_name":"Daniel Prestes","raw_affiliation_strings":["Infectious Diseases, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts/Hospital Emilio Ribas, Sao Paulo, Brazil/Hospital Sirio Libanes, Sao Paulo, Brazil, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts/Hospital Emilio Ribas, Sao Paulo, Brazil/Hospital Sirio Libanes, Sao Paulo, Brazil, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210149843"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019666878","display_name":"Esther Arbona","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Esther Arbona","raw_affiliation_strings":["Infectious Disease, Brigham and Women's Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease, Brigham and Women's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035521199","display_name":"Alexandra Nevett-Fernandez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandra Nevett Fernandez","raw_affiliation_strings":["Brigham and Women Hospital/Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women Hospital/Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042918956","display_name":"Sophia Koo","orcid":"https://orcid.org/0000-0002-4973-7439","observed_orcids":["https://orcid.org/0000-0002-4973-7439"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sophia Koo","raw_affiliation_strings":["Infectious Diseases, Dana-Farber Cancer Institute, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases, Dana-Farber Cancer Institute, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031812464","display_name":"Vincent T. Ho","orcid":"https://orcid.org/0000-0001-6839-3996","observed_orcids":["https://orcid.org/0000-0001-6839-3996"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vincent Ho","raw_affiliation_strings":["Brigham and Women's Hospital/Dana-Farber-Cancer-Institute/Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital/Dana-Farber-Cancer-Institute/Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029390145","display_name":"John Koreth","orcid":"https://orcid.org/0000-0002-7428-1330","observed_orcids":["https://orcid.org/0000-0002-7428-1330"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Koreth","raw_affiliation_strings":["Brigham and Women's Hospital/Dana-Farber-Cancer Institute/Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital/Dana-Farber-Cancer Institute/Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036680177","display_name":"Sarah Page Hammond","orcid":"https://orcid.org/0000-0002-4271-7443","observed_orcids":["https://orcid.org/0000-0002-4271-7443"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah P. Hammond","raw_affiliation_strings":["Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000363583","display_name":"Nicolas C. Issa","orcid":"https://orcid.org/0000-0002-6596-0518","observed_orcids":["https://orcid.org/0000-0002-6596-0518"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicolas Issa","raw_affiliation_strings":["Division of Infectious Diseases, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091029647","display_name":"Lindsey Robert Baden","orcid":"https://orcid.org/0009-0004-1752-1926","observed_orcids":["https://orcid.org/0009-0004-1752-1926"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lindsey Baden","raw_affiliation_strings":["Brigham and Women's Hospital, Infectious Diseases/Dana-Farber-Cancer Institute/Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Infectious Diseases/Dana-Farber-Cancer Institute/Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210161994"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011325960","display_name":"Francisco M. Marty","orcid":"https://orcid.org/0000-0002-3708-8734","observed_orcids":["https://orcid.org/0000-0002-3708-8734"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francisco M. Marty","raw_affiliation_strings":["Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":0.3129,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.70742235,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"3","issue":"suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cytomegalovirus-reactivation","display_name":"cytomegalovirus reactivation","score":0.9909999966621399},{"id":"https://openalex.org/keywords/cytomegalovirus-infection","display_name":"cytomegalovirus infection","score":0.8199999928474426},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9750000238418579},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.7900000214576721},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.8600000143051147},{"id":"https://openalex.org/keywords/philadelphia-chromosome-positive-acute-lymphoblastic-leukemia","display_name":"Philadelphia chromosome-positive acute lymphoblastic leukemia","score":0.9169999957084656},{"id":"https://openalex.org/keywords/cmv-seropositivity","display_name":"CMV seropositivity","score":0.9010000228881836},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.8169999718666077},{"id":"https://openalex.org/keywords/cmv-colitis","display_name":"CMV colitis","score":0.8849999904632568},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.6190000176429749},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.7889999747276306},{"id":"https://openalex.org/keywords/molecular-relapse","display_name":"molecular relapse","score":0.7649999856948853}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9024349451065063},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.7522097826004028},{"id":"https://openalex.org/C2777732132","wikidata":"https://www.wikidata.org/wiki/Q6946","display_name":"Cytomegalovirus","level":5,"score":0.6956139206886292},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.6256331205368042},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5983437895774841},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.5625693798065186},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4696720540523529},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.444233238697052},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38414907455444336},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3323178291320801},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.2287290096282959},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.13162624835968018},{"id":"https://openalex.org/C2776409557","wikidata":"https://www.wikidata.org/wiki/Q149348","display_name":"Herpesviridae","level":4,"score":0.1174832284450531},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.09242117404937744},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06296813488006592},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/ofid/ofw172.1833","doi":"https://doi.org/10.1093/ofid/ofw172.1833","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofw172.1833","pdf_url":"https://academic.oup.com/ofid/article-pdf/3/suppl_1/2286/28689513/ofw172.1833.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofw172.1833","doi":"https://doi.org/10.1093/ofid/ofw172.1833","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofw172.1833","pdf_url":"https://academic.oup.com/ofid/article-pdf/3/suppl_1/2286/28689513/ofw172.1833.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320309052","display_name":"Alexion Pharmaceuticals","ror":"https://ror.org/031ywxc85"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2560048845.pdf","grobid_xml":"https://content.openalex.org/works/W2560048845.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2606880299","https://openalex.org/W4386021530","https://openalex.org/W2979364952","https://openalex.org/W2416358021","https://openalex.org/W7171554725","https://openalex.org/W3096792735","https://openalex.org/W2810881506","https://openalex.org/W2472166008","https://openalex.org/W2514004596","https://openalex.org/W4384134904"],"abstract_inverted_index":{"Background.":[0],"Dasatinib":[1,124,240],"is":[2,48,244],"a":[3,38,197],"second":[4],"generation":[5],"tyrosine":[6],"kinase":[7],"inhibitor":[8],"approved":[9],"for":[10,41,99,130,224],"treatment":[11,134],"of":[12,32,57,136,143,169,199,212,249],"Philadelphia":[13],"positive":[14],"(Ph+)":[15],"hematological":[16],"malignancies.":[17],"CMV":[18,42,80,92,100,112,121,144,148,172,195,213,216,227,236,250,253,256],"infection":[19,43],"has":[20],"been":[21],"reported":[22],"rarely":[23],"in":[24,127,146,163,180,226,255],"patients":[25,59,129,150,181],"with":[26,29,60,193,235,246],"CML":[27,61],"treated":[28],"dasatinib":[30,88,230],"outside":[31],"HSCT,":[33],"but":[34],"its":[35],"role":[36],"as":[37],"risk":[39,248],"factor":[40],"when":[44],"used":[45,126],"after":[46,204],"HSCT":[47,69,76,218,243,258],"not":[49,165],"known.":[50],"Methods.":[51],"We":[52,74,109],"retrospectively":[53],"reviewed":[54],"the":[55],"records":[56],"109":[58],"(46)":[62],"or":[63,95,133,187],"Ph+":[64],"ALL":[65],"(63)":[66],"who":[67],"underwent":[68],"from":[70],"2005":[71],"to":[72],"2015.":[73],"assessed":[75],"characteristics,":[77],"including":[78,190],"recipient":[79],"seropositivity":[81],"(CMV":[82],"R+),":[83],"acute":[84,186],"graft-versus-host":[85],"disease":[86,138,254],"(aGVHD),":[87],"exposure":[89,231],"post-HSCT,":[90,117],"and":[91,184,252,275,279,289,293,298,302,307,311,321,325,330,334],"events":[93,101,113,145,173,237],"(infection":[94],"disease).":[96],"Risk":[97],"factors":[98],"were":[102],"evaluated":[103],"using":[104],"time-dependent":[105],"Cox":[106,208],"modeling.":[107],"Results.":[108],"observed":[110],"23":[111],"by":[114],"one":[115],"year":[116],"only":[118],"among":[119],"63":[120],"R+":[122,149,217,228,257],"patients.":[123,259],"was":[125,151,232],"21":[128],"prevention":[131],"(5)":[132],"(16)":[135],"underlying":[137],"molecular":[139],"relapse.":[140],"Cumulative":[141],"incidence":[142],"dasatinib-exposed":[147],"0.75":[152],"(95%":[153,159],"CI":[154,160],"0.33,":[155],"0.99)":[156],"versus":[157],"0.33":[158],"0.23,":[161],"0.48)":[162],"those":[164],"exposed.":[166],"Interestingly,":[167],"4":[168],"8":[170],"dasatinib-associated":[171],"occurred":[174],"more":[175],"than":[176],"6":[177],"months":[178],"post-HSCT":[179],"off":[182],"immunosuppression":[183],"without":[185],"chronic":[188],"GVHD,":[189],"1":[191],"patient":[192],"proven":[194],"colitis,":[196],"median":[198],"85":[200],"(range":[201],"71\u2013127)":[202],"days":[203],"starting":[205],"dasatinib.":[206],"Table:":[207],"Proportional":[209],"Hazards":[210],"Model":[211],"Reactivation":[214],"Among":[215],"Patients":[219],"(n":[220],"=":[221],"63)":[222],"Adjusting":[223],"aGVHD":[225],"patients,":[229],"significantly":[233],"associated":[234,245],"(table).":[238],"Conclusion.":[239],"use":[241],"post":[242],"increased":[247],"reactivation":[251],"Disclosures.":[260],"F.":[261],"M.":[262],"Marty,":[263],"Alexion:":[264],"Scientific":[265,348],"Advisor,":[266,349],"Consulting":[267,277,291,300,309,317,323,332,350],"fee;":[268,318],"Ansun:":[269],"Investigator,":[270,276,290,299,308,322,331,338],"Research":[271,280,294,303,312,326,335,339],"support;":[272,281,295,304,327,336,340],"Astellas:":[273],"Consultant":[274,288,297,306,320,329],"fee":[278,292,301,310,324,333,351],"Basilea:":[282],"Conference":[283],"speaker,":[284,343],"Speaker":[285,344],"honorarium;":[286,345],"Chimerix:":[287],"Gilead:":[296],"GlaxoSmithKline:":[305],"grant;":[313],"LFB,":[314],"S.A.:":[315],"Consultant,":[316],"Merck:":[319],"Shire:":[328],"WHISCON:":[337],"Pfizer:":[341],"Course":[342],"Fate":[346],"Therapeutics:":[347]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2016-12-16T00:00:00"}